Edition:
United States

People: Novo Nordisk A/S (NOVOb.CO)

NOVOb.CO on Copenhagen Stock Exchange

354.50DKK
23 Aug 2019
Change (% chg)

kr.-0.35 (-0.10%)
Prev Close
kr.354.85
Open
kr.354.40
Day's High
kr.356.20
Day's Low
kr.352.40
Volume
2,055,426
Avg. Vol
2,465,865
52-wk High
kr.356.50
52-wk Low
kr.265.15

Lund, Helge 

Mr. Helge Lund has been Independent Chairman of the Board of Novo Nordisk A/S since March 22, 2018. He has been Independent Director since March 23, 2017. He was previously Independent Director of the Company from March 20, 2014 till March 19, 2015. He formerly served as CEO of Statoil ASA, Norway. He had been Chief executive officer of BG Group, UK, with effect from March 2, 2015. He is Operating Advisor to Clayton Dubilier & Rice, LLC, US. He serves as Member of the boards of P/F Tjaldur, Faroe Islands, Inkerman Holding AS, Norway and Belron S.A., Luxembourg, as well as Member of the board of trustees of the International Crisis Group. He is also Chair of the Board of BP p.l.c. He has executive and board experience in large multinational companies headquartered in Scandinavia within regulated markets, and financial knowledge. He holds Master of Arts in Economics (1987) from the Norwegian School of Economics & Business Administration (NHH) and MBA from INSEAD (1991), France.

Basic Compensation

Total Annual Compensation, DKK 2,700,000
Restricted Stock Awards, DKK --
Long-Term Incentive Plans, DKK --
All Other, DKK --
Fiscal Year Total, DKK 2,700,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --